CpG-DNA as immune response modifier

被引：31
作者：
Dalpke, AH
Heeg, K
机构：
[1] Heidelberg Univ, Dept Hyg & Med Microbiol, Inst Hyg, D-69120 Heidelberg, Germany
[2] Univ Marburg, Inst Med Microbiol & Hyg, D-35037 Marburg, Germany
来源：
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY | 2004年 / 294卷 / 05期
关键词：
CpG-DNA; immunopharmacology; innate immunity; toll-like receptor; sequence motifs;
D O I：
10.1016/j.ijmm.2004.07.005
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Toll-like receptors (TLRs) have been recognized to play a fundamental role in the recognition of microbial pathogens and the activation of innate immunity. However, it has also turned out that triggering of TLRs with purified compounds or synthetic ligands represents a powerful means to modulate innate as well as adaptive immune responses. Among the substances currently under investigation as immune response modifiers CpG-DNA has gained particular interest. One reason for this is the feasibility to easily synthesize and modify immunostimulatory CpG-containing oligodeoxynucleotides (CpG-ODNs). This review deals with the structural needs of CpG-ODNs. CpG-ODNs are discussed as being composed of distinct building blocks (e.g. sequence strings, backbone modifications) giving rise to a concept of structural modules within CpG-ODNs. (C) 2004 Elsevier GmbH. All rights reserved.
引用
收藏
页码：345 / 354
页数：10
相关论文
共 67 条
[1]   Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides [J].
Agrawal, S .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1999, 1489 (01) :53-68
[2]   Medicinal chemistry and therapeutic potential of CpG DNA [J].
Agrawal, S ;
Kandimalla, ER .
TRENDS IN MOLECULAR MEDICINE, 2002, 8 (03) :114-121
[3]   Toll-like receptors differentially induce nucleosome remodelling at the IL-12p40 promoter [J].
Albrecht, I ;
Tapmeier, T ;
Zimmermann, S ;
Frey, M ;
Heeg, K ;
Dalpke, A .
EMBO REPORTS, 2004, 5 (02) :172-177
[4]   Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection [J].
Barry, ME ;
Pinto-González, D ;
Orson, FM ;
McKenzie, GJ ;
Petry, GR ;
Barry, MA .
HUMAN GENE THERAPY, 1999, 10 (15) :2461-2480
[5]  
Bauer S, 2002, CURR TOP MICROBIOL, V270, P145
[6]   Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition [J].
Bauer, S ;
Kirschning, CJ ;
Häcker, H ;
Redecke, V ;
Hausmann, S ;
Akira, S ;
Wagner, H ;
Lipford, GB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (16) :9237-9242
[7]   CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity [J].
Chu, RS ;
Targoni, OS ;
Krieg, AM ;
Lehmann, PV ;
Harding, CV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (10) :1623-1631
[8]   RETRACTED: DNA-PKcs is required for activation of innate immunity by immunostimulatory DNA (Retracted Article) [J].
Chu, WM ;
Gong, X ;
Li, ZW ;
Takabayashi, K ;
Ouyang, HH ;
Chen, Y ;
Lois, A ;
Chen, DJ ;
Li, GC ;
Karin, M ;
Raz, E .
CELL, 2000, 103 (06) :909-918
[9]   Self-stabilized CpG DNAs optimally activate human B cells and plasmacytoid dendritic cells [J].
Cong, YP ;
Song, SS ;
Bhagat, L ;
Pandey, RK ;
Yu, D ;
Kandimalla, ER ;
Agrawal, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 310 (04) :1133-1139
[10]  
Cowdery JS, 1999, J IMMUNOL, V162, P6770
1234567